Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Why Netflix, Inc. (NFLX) Won’t Be Another, Inc. (AMZN) On Profitability: Jim Cramer

Netflix, Inc. (NASDAQ:NFLX) has remained the talk of the week seen by the impressive gains that the stock has amassed in a matter of days having been pounded in the past over a slow growth on subscriptions. CNBC’s, Jim Cramer, notes that any investor who had paid attention to Stifel Nicolaus and Cowen &Co upgrade of the stock could have amassed some of the gains that the stock has generated this week alone.  Unlike Amazon, the analyst expects Netflix to be profitable as push for growth in international markets gains momentum.

Netflix, is NFLX a good stock to buy, content, content distribution, Paul Sweeney, Richard Greenfield, Adam Parker, Tom Keene

Stifel Nicolaus analyst Scott Devitt had upgraded the stock from a Hold to a Buy when it was trading at the $323 mark noting that the company was undergoing a transition to higher subscription growth. Cowen and Co research analyst, John Blackledge, on the other hand having carried out a research on over a thousand Americans found out that most of them were spending more time on Netflix, Inc. (NASDAQ:NFLX) largely because of its original content.

The analyst notes that price increase are no longer a concern to most of the subscribers who continue to yearn for more original content.  Netflix should generate better margins than, Inc. (NASDAQ:AMZN) as subscribers remain receptive to the current prices.

“In fact the survey showed that more Netflix users watch Marco Polo than House of Cards 14% vs. 10%, and this is a virtual cycle of high-quality content that will continue to drive new subscribers. Plus the desire to binge watching in Netflix, Inc. (NASDAQ:NFLX) programming show that prices increases won’t be a problem and that could mean a dramatic increase in profitability down the road,” said Mr. Cramer.

Cramer notes that the analyst did not point out opportunities for growth that Netflix is poised to enjoy on the international front something that justifies a buy at the current margins. The Mad Money Analyst maintains that Netflix subscriptions will no longer be a concern as the company continues to pursue growth away from home.

Netflix, Inc. (NASDAQ:NFLX) is looking to grow its subscription base to 61 million by the end of the year which Cramer believes will further accelerate prospects for profitability.Profitability should kick in as Netflix continues to attract more subscribers unlike, Inc. (NASDAQ:AMZN), despite an increase in subscription fees.

 “[…] The good news here is that in the shareholder letter CEO, Reed Hastings, said because of the low cost of original programming and the ability to get people to sign at reasonable prices which I think means higher prices than now. The company will show material global profitability in 2017, in other words, this won’t be, Inc. (NASDAQ:AMZN),” said Mr. Cramer.

Warren Buffett and BillionairesFree Report: Warren Buffett and 12 Billionaires Are Crazy About These 7 Stocks
Let Warren Buffett, David Einhorn, George Soros, and David Tepper WORK FOR YOU. If you want to beat the low cost index funds by an average of 6 percentage points per year look no further than Warren Buffett’s stock picks. That’s the margin Buffett’s stock picks outperformed the market since 2008. In this free report, Insider Monkey’s market beating research team identified 7 stocks Warren Buffett and 12 other billionaires are crazy about. CLICK HERE NOW for all the details.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!